Publications

View and download slide summaries of the latest original articles focusing on therapies in immune-mediated inflammatory diseases including rheumatology, dermatology, and gastroenterology. All materials produced by the team are subsequently reviewed and approved by individual Steering Committee members.

January 2022

Inhibición de la progresión del daño estructural articular con upadacitinib en arthritis reumatoide: resultados de un año del programa de fase 3 SELECT

Rheumatology (Oxford). 2021. Epub ahead of print. doi: 10.1093/rheumatology/keab861

Hall S,

Durez P,

Shaw T,

Li Y,

Chen S,

Song IH

Keywords:

JAK,
Updacitinib,
Phase 3,
Efficacy,
Radiographic